Director, Scientific Engagement, Crown Bioscience, Inc.
Biography
Rekha is a trained cancer biologist with a focus on preclinical cancer therapeutics, immune-oncology, cancer signaling, and tumor microenvironment. She earned her Ph.D. in Biochemistry from Central Drug Research Institute, India.
She joined the University of Pittsburgh as a postdoctoral researcher and moved onto research faculty. She has extensively worked in stem cell biology and translational cancer research using patient's blood, tumor and bone marrow samples with a correlation of clinical data for the targeted biomarker identification with the drug treatment.
She joined National Surgical Adjuvant Breast and Bowel project (NSABP), a clinical trial supportive group to develop strategies for preclinical evaluation of test agents to support NSABP's phase I/II clinical trials for colon and breast cancer. She also led the effort of organoids generation from the PDX tumor tissue to screen drug or drugs combination as personalized medicine. Rekha represented NSABP as a translational research committee member on B-50 Katherine-B027938 Roche study.
Rekha role at CrownBio is to direct scientific engagement with pharmaceutical company, academic scientists, and clients. She helps in decision making with goal of high scientific input in study design and model execution. Exchange scientific information for existing and new opportunities between BD and the scientific team, generate protocols, study designs and proposals to define projects/ studies.
She joined the University of Pittsburgh as a postdoctoral researcher and moved onto research faculty. She has extensively worked in stem cell biology and translational cancer research using patient's blood, tumor and bone marrow samples with a correlation of clinical data for the targeted biomarker identification with the drug treatment.
She joined National Surgical Adjuvant Breast and Bowel project (NSABP), a clinical trial supportive group to develop strategies for preclinical evaluation of test agents to support NSABP's phase I/II clinical trials for colon and breast cancer. She also led the effort of organoids generation from the PDX tumor tissue to screen drug or drugs combination as personalized medicine. Rekha represented NSABP as a translational research committee member on B-50 Katherine-B027938 Roche study.
Rekha role at CrownBio is to direct scientific engagement with pharmaceutical company, academic scientists, and clients. She helps in decision making with goal of high scientific input in study design and model execution. Exchange scientific information for existing and new opportunities between BD and the scientific team, generate protocols, study designs and proposals to define projects/ studies.
